Confusoside from Anneslea fragrans Alleviates Acetaminophen-Induced Liver Injury in HepG2 via PI3K-CASP3 Signaling Pathway
Molecules · 2023
DOI: 10.3390/molecules28041932 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Jing-Hao Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission and Ministry of Education, Yunnan Minzu University, Kunmin…. Hauptthemen laut MEDLINE: Acetaminophen, Chemical and Drug Induced Liver Injury, Phytochemicals. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, China Postdoctoral Science Foundation, Yunnan Major Natural Science Foundation.
Abstract (Originalsprache)
Confusoside (CF), a major chemical compound in the leaves of Anneslea fragrans Wall., is a dihydrochalcone glycoside with excellent antioxidant and anti-inflammatory effects. However, the hepatoprotective effect of CF has not been described. This study aimed to explore the hepatoprotective effect of CF against acetaminophen (APAP)-induced hepatic injury in HepG2 cells. First, the potential hepatoprotective effect mechanisms of CF were predicted by network pharmacology and were thought to involve reducing inflammation and inhibiting apoptosis. Target proteins (phosphatidylinositol3-kinase (PI3K) and caspase-3 (CASP3)) were found via molecular docking analysis. To verify the predicted results, an analysis of biological indicators was performed using commercial kits and Western blotting. The results showed that CF significantly decreased the levels of liver injury biomarkers (ALT, AST, and LDH), strongly inhibited the production of inflammatory cytokines (IL-1β, IL-6, and TNF-α) and the NO level via inhibiting the activation of the NF-κB signaling pathway, and markedly regulated the expression levels of Bcl2, Bax, and cleaved-CASP3/9 proteins by activating the PI3K-CASP3 apoptosis pathway. The results demonstrated that CF has a therapeutic effect on APAP-induced liver injury by inhibiting intracellular inflammation and cell apoptosis, indicating that CF may be used as a potential reagent for the prevention and treatment of APAP-induced liver injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission and Ministry of Education, Yunnan Minzu University, Kunming 650500, China.
- Department of Information, The First People's Hospital of Yunnan, Kunming 650021, China.
- The faculty of Food Science and Engineering, Kunming University of Science and Technology, Kunming 650500, China.
- School of Chemistry and Environment, National and Local Joint Engineering Research Center for Green Preparation Technology of Biobased Materials, Yunnan Minzu University, Kunming 650500, China.
Förderung
- NIA NIH HHS
- China Postdoctoral Science Foundation
- Yunnan Major Natural Science Foundation
- Major Science and Technology Project of Yunnan Province
- Key Laboratory of Chemistry in Ethnic Medicinal Resources (Yunnan Minzu University), State Ethnic Affairs Commission and Ministry of Education
Zitieren
APA
Zhao, J. H., Li, J., Zhang, X. Y., Shi, S., Wang, L., Yuan, M. L., Liu, Y. P., & Wang, Y. D. (2023). Confusoside from Anneslea fragrans Alleviates Acetaminophen-Induced Liver Injury in HepG2 via PI3K-CASP3 Signaling Pathway. Molecules. https://doi.org/10.3390/molecules28041932
Vancouver
Zhao JH, Li J, Zhang XY, Shi S, Wang L, Yuan ML, et al. Confusoside from Anneslea fragrans Alleviates Acetaminophen-Induced Liver Injury in HepG2 via PI3K-CASP3 Signaling Pathway. Molecules. 2023. doi:10.3390/molecules28041932
BibTeX
@article{Zhao2023,
author = {Zhao, Jing-Hao and Li, Jing and Zhang, Xiao-Yu and Shi, Shang and Wang, Lin and Yuan, Ming-Long and Liu, Ya-Ping and Wang, Yu-Dan},
title = {Confusoside from Anneslea fragrans Alleviates Acetaminophen-Induced Liver Injury in HepG2 via PI3K-CASP3 Signaling Pathway},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28041932}
}
EUVIMED